トラウマ性肋骨骨折の患者における鎮痛のためのデクスメドトミジン: ランダム化臨床試験
Jeffry Nahmias1, Stephen Stopenski1, Mallory Jebbia1
1Department of Surgery, University of California, Irvine, Orange.
JAMA surgery
|September 3, 2025
まとめ
添加用デクスメドトミジンは,肋骨骨折の非インチューブドトラウマ患者のオピオイド使用を減少させたり,疼痛スコアを改善しませんでした. この研究では,デクメデトミジンはこの患者群の鎮痛に有益でないことが示されています.
科学分野:
- トラウマ・クリティカルケア
- 痛みの管理
- 薬理学について
背景:
- トラウマ的な肋骨骨折は 肺の合併症や長期間のオピオイド使用を含む 深刻な病気の原因となります
- オピオイドの摂取を減らすための有効で安全な補助的鎮痛薬の特定は,インチューブされていないトラウマ患者の臨床上の優先事項です.
研究 の 目的:
- 標準的なマルチモダル鎮痛剤に添加されたデクスメドトミジンは,重症病棟 (ICU) の患者にトラウマ性肋骨骨折を伴うオピオイドの摂取量を減少させるかどうかを評価する.
- 痛みのスコアと肺合併症に対するデクスメドトミジンの影響を評価する.
主な方法:
- 予備的,ランダム化,ダブルブラインド,プラセボ対照試験で,インチューブ化されていない成人トラウマ患者41人が参加した.
- 患者は,標準的な疼痛管理に加えて,最大48時間,継続的な静脈内デクスメドトミジンまたはプラセボを投与された.
- 主要アウトカム:数値疼痛スコア (NPS);次要アウトカム:口服用モルヒネ等価量 (OME) と肺合併症.
主要な成果:
- デキスメドトミジンとプラセボのグループでは,基値の有意な差異はありません.
- 48時間後の平均OMEは,デクスメデトミジン群 (125. 5 mg) でプラセボ群 (87. 1 mg) よりも高かった.
- NPSの平均値,肺合併症の発生率,ICUの滞在期間はグループごとに似ていた. デキメドトミジンの投与は 47. 4%で副作用により中止された.
結論:
- 補助的なデクスメドトミジンは,非インチューブされたICU患者で,トラウマ性肋骨骨折で,オピオイドの消費を減少させたり,痛みのスコアを改善しなかった.
- 研究結果は,この特定の患者集団において,デクスメドトミジンの常時的鎮痛薬の使用を支持しません.
- 重度の肋骨骨折に対する代替的鎮痛策を探るには,さらなる研究が必要である.
関連する概念動画
Parenteral Anesthetics: Overview
196
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
196
Skeletal Muscle Relaxants: Therapeutic Uses
612
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
612
Local Anesthetics: Clinical Application as Epidural Anesthesia
498
Epidural anesthetics are administered in the fat-filled epidural space, the outermost part of the spinal canal. This technique is commonly employed for pain management and anesthesia during lower abdomen and pelvis surgeries or labor and delivery.
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
498
Flail Chest-II
234
Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:
Assessment:
1. Clinical Evaluation:
History:
234
Analgesia and Pain Management
788
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
788
Opioid Analgesics: Synthetic and Semisynthetic Opioids
421
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
421


